Keyphrases
High Dose
100%
Myocardial Infarction
100%
Left Ventricular Function
100%
Diltiazem
100%
Early Course
100%
Placebo
45%
Radionuclides
45%
Ventriculography
45%
Non-Q-wave Myocardial Infarction
45%
Regional Wall Motion
36%
Wall Motion Score Index
27%
Acute Myocardial Infarction
18%
Reinfarction
18%
Calcium Channel Blockers
18%
Treatment Group
9%
Clinically Significant
9%
Angina
9%
Pre-discharge
9%
Heart Failure
9%
Left Ventricular Ejection Fraction
9%
Congestive Heart Failure
9%
MB Creatine Kinase
9%
Post-infarction
9%
Ejection Fraction
9%
Between-group Difference
9%
Early-late
9%
Nitrate
9%
Beta-blockers
9%
Concurrent Treatment
9%
Radionuclide Ventriculography
9%
Group Assignment
9%
Regional Function
9%
Beta-blocker Therapy
9%
Standard Medical Therapy
9%
Group Consensus
9%
Dyskinetic
9%
Placebo Treatment
9%
Negative Inotropic Effect
9%
Adverse Drug Effects
9%
Long-acting Nitrates
9%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Diltiazem
100%
Placebo
54%
Radioisotope
54%
Congestive Heart Failure
18%
Acute Heart Infarction
18%
Calcium Channel Blocker
18%
Beta Adrenergic Receptor Blocking Agent
18%
Combination Therapy
9%
Creatine Kinase MB
9%
Nitric Acid Derivative
9%
Adverse Drug Reaction
9%
Treatment Group
9%
Neuroscience
Myocardial Infarction
100%
Diltiazem
100%
Placebo
54%
Beta Blocker
18%
Calcium Channel Blocker
18%
Creatine Kinase MB
9%